Latest Eli Lilly and Company News & Updates

See the latest news and media coverage for Lilly. We track all announcements, press releases, and industry mentions in real time, all in one place.

Eli Lilly and Company (Lilly)

Global biopharmaceutical company

lilly.com

Headquarters: Indianapolis, United States
Company type: Public company
Number of employees: 55,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about Eli Lilly and Company (Lilly)

In short: Lilly expanded its weight-loss portfolio, acquired AtaiBeckley for $2.8 billion, and faced a U.S. probe into its drug trials in China.

Company announcements

July 23 Lilly

Lilly's retatrutide succeeds in two Phase 3 obesity trials

The drug achieved up to 22.6% weight loss and A1C reductions of 1.6% in patients with type 2 diabetes and cardiovascular disease.

July 22 Lilly

Lilly announces Q2 2026 financial results date

Results will be released August 5, 2026, followed by a conference call at 10 a.m. Eastern.

July 16 Lilly

Lilly acquires AtaiBeckley for depression therapies

The acquisition includes BPL-003, a synthetic 5-MeO-DMT for treatment-resistant depression, with a $2.8B upfront and up to $1B in milestones.

June 26 Lilly

Lilly's Jaypirca recommended by CHMP for EU approval for CLL

The positive opinion is based on Phase 3 BRUIN CLL-313 and BRUIN CLL-314 trials.

Media coverage

July 31 Hoodline

Michigan Supreme Court Opens Door To Nessel’s Eli Lilly Probe

Michigan’s top court just reopened the door to an insulin-pricing probe targeting Eli Lilly, with potential consequences for regulated businesses statewide.

July 31 Barron's

Here Comes the Next Wave of GLP-1s. They’ll Treat a Lot More Than Obesity.

This blockbuster class of drugs is shattering all sales records. Which stock will do better—Eli Lilly or Novo Nordisk?

July 30 Indianapolis Business Journal

Lilly partners with Ohio-based company on $750M manufacturing expansion

The expansion will boost production of Lilly's KwikPen injectable device, which is used to deliver diabetes and obesity medications Mounjaro and Zepbound.

July 30 Yahoo Finance

Resilience and Lilly invest $750M to scale Cincinnati medicine output

The expansion will create 400 jobs dedicated to GLP-1 injectables production across Resilience's contract manufacturing facilities.

Never miss news about Lilly

Track Lilly and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Lilly competitors & trending companies

Browse news for competitors to Lilly and other trending companies.